Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

CANCELLED - ESMO Targeted Anticancer Therapies Congress 2020

Name: ESMO Targeted Anticancer Therapies Congress 2020
Start: 2020-03-01T23:00:00+00:00
End: 2020-03-04T22:59:00+00:00
Location: ESMO Targeted Anticancer Therapies Congress 2020

Programme Congress Coverage Congress Officers Industry Sponsored Satellite Symposia Industry Participation Contacts

Start date: 02 Mar 2020
End date: 04 Mar 2020
Location: Paris, France

The TAT Congress has firmly established itself as the must-attend forum for all experts focusing on early phase drug development and translational research.

Stakeholders from academia and industry meet with clinicians, researchers and regulators from all around the world to facilitate the development of new anti-cancer treatments and make more options available to patients.

The TAT Congress series has effectively transformed the landscape of early drug development and you have the opportunity to be a part of a highly influential meeting.

CORONAVIRUS: Update from ESMO